Publicaciones

Affichage de 121 à 130 sur 2052


  • Article dans une revue

Deep reinforcement learning with predictive auxiliary task for autonomous train collision avoidance

Antoine Plissonneau, Luca Jourdan, Damien Trentesaux, Lotfi Abdi, Mohamed Sallak, Abdelghani Bekrar, Benjamin Quost, Walter Schön

The contribution of this paper consists of a deep reinforcement learning (DRL) based method for autonomous train collision avoidance. While DRL applied to autonomous vehicles’ collision avoidance has shown interesting results compared to traditional methods, train-like vehicles are not currently...

Journal of Rail Transport Planning & Management, 2024, 31, pp.100453. ⟨10.1016/j.jrtpm.2024.100453⟩. ⟨hal-04607863⟩

  • Article dans une revue

Wet foam flow for cleaning food industry equipment: Role of geometry in maintaining removal efficiency of Bacillus spores.

Heni Dallagi, Carolina Dari, Fameau Anne-Laure, Fethi Aloui, Christine Faille, Thierry Benezech

Journal of Food Engineering, 2024, 376, pp.112064. ⟨10.1016/j.jfoodeng.2024.112064⟩. ⟨hal-05621287⟩

  • Article dans une revue

Iterated local search with ejection chains for the space-free multi-row facility layout problem

Song Wu, Wei Yang, Saïd Hanafi, Christophe Wilbaut, Yang Wang

European Journal of Operational Research, 2024, 316 (3), pp.873-886. ⟨10.1016/j.ejor.2024.03.012⟩. ⟨hal-05159499⟩

  • Article dans une revue

The EMMY longitudinal, cohort study: real-world data to describe multiple myeloma management and outcomes as more therapeutic options emerge

Olivier Decaux, Ronan Garlantézec, Karim Belhadj-Merzoug, Margaret Macro, Laurent Frenzel, Aurore Perrot, Philippe Moreau, Bruno Royer, Denis Caillot, Xavier Leleu, Mohamad Mohty, Lionel Karlin, Pierre Feugier, Sophie Rigaudeau, Jean Fontan, Cécile Sonntag, Laure Vincent, Thomas Chalopin, Herve Avet Loiseau, Zakaria Maarouf, Louni Chanaz, Nathalie Texier, Cyrille Hulin

The therapeutic management of patients with multiple myeloma (MM) is complex. Despite substantial advances, MM remains incurable, and management involves cycles of treatment response, disease relapse, and further therapy. Currently, evidence to support the therapeutic decision is limited. Thus, the...

Clinical Hematology International, 2024, 6 (3), pp.22-27. ⟨10.46989/001c.121371⟩. ⟨hal-04915075⟩